Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-05-23
1998-12-01
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 23, 514 32, 514 43, 514259, 514283, 514371, 514372, 514377, 514387, 514397, 514407, 514410, 514411, 536 173, 536 286, 536115, 540222, 548181, 548233, 548245, 548246, 5482654, 5483041, 5483117, 5483121, 5483647, 548421, 548425, 548427, 548428, 548433, A61K 3140, A61K 31545, C07D48704, C07D50122
Patent
active
058439374
ABSTRACT:
The present invention relates to novel DNA alkylating agents and the prodrugs of these agents which are useful as antitumor agents and DNA labelling agents. The compounds are hydroxy dihydrobenzindole oligopeptides and prodrugs thereof wherein the monomeric constituents are derived from monocyclic or bicyclic heterocyclic aromatic residues.
REFERENCES:
patent: 5502068 (1996-03-01), Lown et al.
Boger, Dale L., et al.; "Duocarmycin SA Shortened, Simplified, and Extended Agents: A Systematic Examination of the Role of the DNA Binding Subunit"; J. Am. Chem., Soc, ; 119:4977-4986 (1997).
P. Aristoff et al., Advances in Medicinal Chemistry, 2:67-110 (1993).
P. Aristoff et al., J. Med. Chem., 36:1956-1963 (1993).
D. Boger et al., Bioorganic & Medicinal Chemistry, 3(6):611-621 (1995).
D. Boger et al., Bioorganic & Medicinal Chemistry, 3(6):761-775 (1995).
D. Boger et al., Bioorganic & Medicinal Chemistry, 3(11):1429-1453 (1995).
D. Boger et al., J. Am. Chem. Soc., 112:4623-4632 (1990).
D. Boger et al., J. Am. Chem. Soc., 116:7996-8006 (1994).
D. Boger et al., Proc. Natl. Acad. Sci. USA, 92:3642-3649 (Apr. 1995).
R. Chari et al., Cancer Research, 55:4079-4084 (1995).
N. Fregeau et al., J. Am. Chem. Soc., 117:8917-8925 (1995).
L. Hurley et al., J. Am. Chem. Soc., 112:4633-4649 (1990).
Y. Wang et al., Book of Abstracts, 209th ACS National Meeting, Apr. 2-6, 1995, Anaheim, California.
Y. Wang et al., J. Med. Chem., 31:590-603 (1988).
Y. Wang et al., Anti-Cancer Drug Design, 11:15-34 (1996).
Larrick James W.
Wang Yuqiang
Wright Susan C.
Panorama Research, Inc.
Raymond Richard L.
LandOfFree
DNA-binding indole derivatives, their prodrugs and immunoconjuga does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA-binding indole derivatives, their prodrugs and immunoconjuga, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-binding indole derivatives, their prodrugs and immunoconjuga will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395777